"Very good information provided to make statistics interesting that applied to DOE."
- R. Marchesani, Head, West Coast Operations, Biologics Consulting Group
"Great conference with many valuable topics covered"
- M. Kane, Associate Director, Process Statistics, HGSI
IBC's 13th International Process Validation for Biopharmaceuticals was one of 5 conferences that took place during Biopharmaceutical Development & Production Week which took place on March 2-6, 2009 in Carlsbad, CA.
By providing a strong emphasis on Quality by Design, Design of Experiments and process understanding, this year's conference allowed attendees to learn how to apply new approaches to process validation in order to establish best practices that could be immediately implemented at their organizations. Attendees gathered at this year's conference to:
Conference Highlights Included:
Keynote Presentation:
Critical Quality Attributes: The Foundation of QbD and Process Validation
Ron Taticek, Ph.D.
Director, CMC Regulatory Affairs
Genentech, Inc.
Featured Session:
Continuous Improvement in the Low Cost Manufacturing of Bovine Somatotropin
Brad Storrs, Ph.D., Senior Fellow and Bioprocess Technology Lead, Monsanto Company
Session Topics Covered:
This conference was conveniently co-located with Technology Transfer and Outsourcing Manufacturing of Biopharmaceuticals giving attendees access to these additional conferences and networking in the shared exhibit hall which featured over 33 booths.
Planning is now underway for Biopharmaceutical Development & Production week 2010 which will return to the La Costa Resort and Spa on March 1-5, 2010. Join the Process Validation for Biopharmacetuicals priority contact list for latest updates on this conference for 2010!
Copyright IBC Life Sciences, a part of Informa Life Sciences Group